ReachMD

Popular

• • 

    

    Javed Butler, MD, MPH, MBA

    Peer

  • 

    

    Peter van der Meer, MD, PhD

    Peer

  6

  

  RestartResume

  Common Misconceptions About Iron Deficiency in Heart Failure and What to Do About It

  0.25 credits

• • 

    

    Kevin Brown, MD

    Peer

  • 

    

    Kevin R. Flaherty, MD

    Peer

  • 

    

    Rebecca C. Keith, MD

    Peer

  2

  

  RestartResume

  Emerging Treatments: Diagnosis and Treatment of Chronic Fibrosing ILD with a Progressive Lung Disease Phenotype

  1.00 credits

• • 

    

    Mikhail Kosiborod, MD

    Peer

  6

  

  RestartResume

  CARE HK in HF: Designing a Real-world Study to Identify Barriers to Guideline-directed RAASi Therapy

• • 

    

    William Mencia, MD, FACEHP, CHCP

    Peer

  • 

    

    Gregory S. Sawicki, MD, MPH

    Peer

  2

  

  RestartResume

  Cystic Fibrosis: Overcoming Barriers to Nutrition Adherence

  0.25 credits

• • 

    

    Keith S. Kaye, MD, MPH

    Peer

  • 

    

    Marin H. Kollef, MD, FACP, FCCP

    Peer

  • 

    

    Douglas N. Fish, PharmD

    Peer

  3

  

  RestartResume

  Critical Updates in Treating Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

  0.25 credits

• • 

    

    Pradeep Y. Ramulu, MD, PhD

    Peer

  • 

    

    E. Randy Craven, MD

    Peer

  • 

    

    Mark T. Dunbar, OD, FAAO

    Peer

  4

  

  RestartResume

  Innovations in Glaucoma Therapy

  0.25 credits

• • 

    

    Charles Daley, MD

    Peer

  • 

    

    Shannon H. Kasperbauer, MD

    Peer

  1

  

  RestartResume

  Improving Outcomes in NTM-LD: Strategies for Diagnosis, Individualized Treatment Plans and Patient Adherence

  1.00 credits

• • 

    

    Linda Bernstein, Pharm.D.

    Peer

  3

  

  RestartResume

  FDA Approves Remdesivir, the First COVID-19 Treatment

• • 

    

    Yehuda Handelsman, MD

    Peer

  • 

    

    Deepak L. Bhatt, MD, MPH, FACC, FAHA, FSCAI, FESC

    Peer

  • 

    

    Om P. Ganda, MD

    Peer

  • 

    

    Jorge Plutzky, MD

    Peer

  • 

    

    Paul D. Rosenblit, MD, PhD, FACE, FNLA

    Peer

  2

  

  RestartResume

  Hot Topics in Omega-3s and ASCVD Risk Reduction in Diabetes

  2.50 credits

• • 

    

    Linda Bernstein, Pharm.D.

    Peer

  3

  

  RestartResume

  CDC Playbook for COVID-19 Vaccine Distribution

• • 

    

    Mindie H. Nguyen, MD, MAS, AGAF, FAASLD

    Peer

  • 

    

    Raymond Chung, MD

    Peer

  • 

    

    Douglas Dieterich, MD, FACP

    Peer

  3

  

  RestartResume

  Enhancing Medication Adherence, Retention, and Care for Hepatitis B Patients

  0.25 credits

• • 

    

    Eric Simpson, MD, MCR

    Peer

  • 

    

    Jonathan I. Silverberg, MD, PhD, MPH

    Peer

  0

  

  RestartResume

  Understanding the Pathophysiology of Atopic Dermatitis: Have We Only Scratched the Surface?

• • 

    

    Jennifer Caudle, DO

    Peer

  • 

    

    Lawrence F. Eichenfield, MD

    Peer

  1

  

  RestartResume

  Late-Breaking Data in Moderate-to-Severe Atopic Dermatitis

  0.25 credits

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  4

  

  RestartResume

  Part 1: Are You Ready for Biosimilars? What the Oncology Team Should Know

• • 

    

    Matt Birnholz, MD

    Peer

  • 

    

    Gary Cohen, MD

    Peer

  3

  

  RestartResume

  Part 2: Are You Ready for Biosimilars? What the Oncology Team Should Know